Shawn McCormick is Director at Inspire Medical Systems, Inc. (INSP). They have made 6 open-market trades across 3 companies since 2009, most recently 2026-05-08.
CIK 0001454092
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $270K since 2015, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INSP | SELL · 10b5-1 | 2026-05-08 | 2026-05-11 | $45.31 | $32K | +1.3% | -4.2% | +35.5% |
| INSP | SELL · 10b5-1 | 2025-12-02 | 2025-12-04 | $139.00 | $167K | -17.7% | -32.4% | -54.1% |
| INSP | SELL · 10b5-1 | 2025-11-28 | 2025-12-01 | $127.48 | $255K | +9.8% | -26.3% | -48.2% |
| INSP | SELL · 10b5-1 | 2025-05-02 | 2025-05-05 | $160.00 | $58K | +3.5% | -4.7% | -10.2% |
| INSP | SELL · 10b5-1 | 2024-09-09 | 2024-09-11 | $220.00 | $176K | +6.7% | +3.8% | -6.7% |
| NVRO | BUY | 2023-06-07 | 2023-06-09 | $22.88 | $172K | +11.7% | +6.4% | -13.7% |
| NVRO | SELL | 2021-05-24 | 2021-05-26 | $149.65 | $144K | +2.1% | +19.3% | -22.7% |
| NVRO | SELL | 2020-05-21 | 2020-05-26 | $126.50 | $129K | -0.7% | -6.4% | +2.1% |
| NVRO | SELL | 2019-11-11 | 2019-11-13 | $104.35 | $83K | +5.9% | +3.2% | +31.5% |
| INSP | BUY | 2018-05-07 | 2018-05-09 | $16.00 | $48K | +37.3% | +39.4% | +90.5% |
| TRNX | SELL · 10b5-1 | 2015-06-03 | 2015-06-05 | $26.50 | $98K | N/A | N/A | N/A |
| ENTL | BUY | 2015-02-03 | 2015-02-04 | $17.00 | $50K | -6.0% | +3.4% | +3.4% |
| TRNX | SELL · 10b5-1 | 2014-06-03 | 2014-06-05 | $21.42 | $61K | N/A | N/A | N/A |
| TRNX | SELL · 10b5-1 | 2013-06-03 | 2013-06-05 | $15.81 | $19K | N/A | N/A | N/A |
| EVVV | SELL · 10b5-1 | 2009-11-16 | 2009-11-17 | $12.16 | $66K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.